André N Vis

9PUBLICATIONS
35CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer diagnosisCentral nervous systemCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 15, 2026
Leveraging [<sup>18</sup>F]F-Piflufolastat PET for PBPK Prediction of Tissue Distribution and Therapy Optimization in Prostate Cancer.

|Sep 23, 2024
The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients-towards a tumor volume-based risk stratification.

Marinus J Hagens, Wietske I Luining, Liselotte M S Boevé

|Sep 12, 2024
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics.

Matthew J Roberts, Nathan Papa, Hans Veerman

|Sep 02, 2023
Histopathological concordance between prostate biopsies and radical prostatectomy specimens-implications of transrectal and transperineal biopsy approaches.

M J Hagens, L L A Ribbert, A Jager

|Dec 22, 2022
NeuroSAFE remains an investigational, debatable, laborious (expensive) procedure.

André N Vis, Jakko A Nieuwenhuijzen, Hans Veerman

|Sep 19, 2022
The oncological characteristics of non-prostate-specific membrane antigen (PSMA)-expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography.

Hans Veerman, Maarten Donswijk, Elise Bekers

Pageof 2

Frequent Collaborators

4 joint publications

Hans Veerman

4 joint publications

Daniela E Oprea-Lager

4 joint publications

Henk G van der Poel

2 joint publications

Marinus J Hagens